Severe symptomatic intracranial internal carotid artery stenosis treated with intracranial stenting: a single center study with 58 patients

CONCLUSION Intracranial stenting for patients with intracranial ICA atherosclerotic stenosis has a low perioperative stroke rate and decent outcome on long-term follow-up, despite a relatively high in-stent restenosis rate.

📌 3 Maddede Bu Makale

🎯

Amaç & Hipotez:We aimed to investigate the safety and effectiveness of intracranial stenting in a population with severe (>=70%) symptomatic intracranial internal carotid artery (ICA) atherosclerotic stenosis.

📊

Temel Bulgular & Veri:The baseline data, cerebral angiography, success rate, perioperative complications, clinical and imaging follow-up were prospectively analyzed.

💡

Sonuç & Katkı:CONCLUSION Intracranial stenting for patients with intracranial ICA atherosclerotic stenosis has a low perioperative stroke rate and decent outcome on long-term follow-up, despite a relatively high in-stent restenosis rate.

🔬Tür:Araştırma Makalesi

📍Kapsam:Genişletilmiş Akademik Örneklem

⚙️Değişkenler:Alan Parametreleri

Abstract

We aimed to investigate the safety and effectiveness of intracranial stenting in a population with severe (>=70%) symptomatic intracranial internal carotid artery (ICA) atherosclerotic stenosis. METHODS Fifty-eight patients with severe intracranial ICA atherosclerotic stenosis were prospectively enrolled. The baseline data, cerebral angiography, success rate, perioperative complications, clinical and imaging follow-up were prospectively analyzed. RESULTS All patients had successful intracranial stenting (100%), and the mean degree of stenosis was improved from 84.3%±7.5% to 23.5%±5.1% after the stent procedure. During the 30-day perioperative period, only one patient (1.7%) had ischemic stroke. Seven patients (12.1%) had headache and dysphoria. Thirty-six patients (62.1%) had clinical follow-up for 6-68 months after stenting. Five female patients (13.9%) had ipsilateral stroke including one death, but no disabling stroke, while three other patients (8.3%) had ipsilateral temporary ischemic attack (TIA). The recurrent stroke rate was higher in patients presenting with stroke (4/17, 23.5%) than in patients presenting with TIA (1/19, 5.3%), with no statistical significance (P = 0.33). Thirteen patients (22.4%) had imaging follow-up of 5-12 months following stenting, five of whom (38.5%) had in-stent restenosis. CONCLUSION Intracranial stenting for patients with intracranial ICA atherosclerotic stenosis has a low perioperative stroke rate and decent outcome on long-term follow-up, despite a relatively high in-stent restenosis rate.

🔖

Bu Makaleye Atıf Yap

WANG, Z., GAO, B., Li, T., CAİ, D., SHU, L., XuE, J., BAi, W. X., Lİ, Z. (2016). Severe symptomatic intracranial internal carotid artery stenosis treated with intracranial stenting: a single center study with 58 patients. Diagnostic and Interventional Radiology, Cilt: 22 - Sayı: 2, 178–183. https://ajindex.com/articles/350109

Kaynakça (2)

Huang YN, Gao S, Li SW, et al. Vascular lesions in Chinese patients with transient ischemic at- tacks. Neurology 1997; 48:524-525. [CrossRef] Derdeyn CP, Chimowitz MI, Lynn MJ, et al. Aggres- sive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet 2014; 383:333-341. [CrossRef] Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refracto- ry intracranial atherosclerotic stenoses: the Wing- span study. Stroke 2007; 38:1531-1537. [CrossRef] Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007; 38:881-887. [CrossRef] Jiang WJ, Yu W, Du B, Gao F, Cui LY. Outcome of patients with >/=70% symptomatic intracra- nial stenosis after Wingspan stenting. Stroke 2011; 42:1971-1975. [CrossRef] Albuquerque FC, Levy EI, Turk AS, et al. Angio- graphic patterns of Wingspan in-stent resteno- sis. Neurosurgery 2008; 63:23-28. [CrossRef] Turk AS, Levy EI, Albuquerque FC, et al. Influ- ence of patient age and stenosis location on wingspan in-stent restenosis. AJNR Am J Neu- roradiol 2008; 29:23-27. [CrossRef] Kasner SE, Lynn MJ, Chimowitz MI, et al. War- farin vs. aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neu- rology 2006; 67:1275-1278. [CrossRef] Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Associa- tion. Stroke 2011; 42:227-276. [CrossRef] Nakamura K, Sugimura K, Takahashi Y. Carotid artery stenting. Masui 2012; 61:1205-1215.
Fiorella D, Derdeyn CP, Lynn MJ, et al. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Pre- venting Recurrent Stroke in Intracranial Steno- sis (SAMMPRIS). Stroke 2012; 43:2682-2688. [CrossRef] Fiorella DJ, Turk AS, Levy EI, et al. U.S. Wingspan Registry: 12-month follow-up results. Stroke 2011; 42:1976-1981. [CrossRef] Zaidat OO, Klucznik R, Alexander MJ, et al. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial steno- sis. Neurology 2008; 70:1518-1524. [CrossRef] Ascher E, Markevich N, Schutzer RW, Kallakuri S, Jacob T, Hingorani AP. Cerebra